Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CVS Health : Bernstein Adjusts CVS Health's Price Target to $100 from $107, Keeps Outperform Rating

09/08/2021 | 10:00am EST


ę MT Newswires 2021
All news about CVS HEALTH CORPORATION
06:13aNORTH AMERICAN MORNING BRIEFING : Oil Rises, Stock Futures Waver as Markets Cap Volatile W..
DJ
12/02U.S. OMICRON PLAN : boosters, free at-home tests, tighter travel rules
RE
12/02U.S. OMICRON PLAN : boosters, free at-home tests, tighter travel rules
RE
12/02CVS HEALTH : named to 2021 Dow Jones Sustainability Index
PU
12/01CVS Health to Invest $9.2 Million in Affordable Housing in Washington, D.C.
PR
12/01WALL STREET STOCK EXCHANGE : The Fed takes a new stance
12/01ANALYST RECOMMENDATIONS : American Water, CVS, D.R. Horton, Ferrari, Marvell Technology.....
12/01Seaport Global Starts CVS Health at Buy With $110 Price Target
MT
12/01CVS Health to Invest $9.2 Million in Affordable Housing in Washington, D.C
CI
11/29CVS HEALTH : President and CEO Karen Lynch comments on White House supply chain meeting, i..
PU
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2021 289 B - -
Net income 2021 8 070 M - -
Net Debt 2021 48 101 M - -
P/E ratio 2021 14,6x
Yield 2021 2,20%
Capitalization 120 B 120 B -
EV / Sales 2021 0,58x
EV / Sales 2022 0,54x
Nbr of Employees 256 500
Free-Float 75,7%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 90,87 $
Average target price 105,56 $
Spread / Average Target 16,2%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Sector and Competitors